Other Meetings

Other Meetings

On-site reporting from other meetings and summits in the hematology/oncology arena

On location

Pilot Study Finds Remote Monitoring of Patients Undergoing Chemotherapy Feasible

Using technology to monitor outpatients undergoing cancer treatments at home was feasible and led to improvements in care, according to results of a pilot...
On location

Could AP-Led Quality and Safety Grand Rounds Improve Patient Outcomes?

Grand rounds provide an opportunity for oncology advanced practitioners (APs) to discuss quality and safety across disciplines and may have positive effects on patient...
On location

Amino Acids Could Reduce Cancer Treatment–Related Diarrhea

Treatment-related diarrhea is a common adverse event (AE) associated with cancer-directed therapies, negatively affecting patients’ quality of life (QOL) and leading to treatment delays...
On location

Study Highlights Barriers to Greater AP Understanding of Immuno-oncology

According to results from a survey of U.S. oncology advanced practitioners (APs), APs express growing familiarity with immuno-oncology (IO) therapies, though issues such as...
On location

Does Rehabilitation Improve Physical Well-Being and Quality of Life for Cancer Survivors?

Individualized rehabilitative instruction may lead to improvements in quality of life and significant physical benefits for cancer survivors, according to findings presented at JADPRO...
On location

A New Clinical Ladder for Advanced Practitioners Improves Retention, Engagement

Five years after implementing a “clinical ladder” for advanced practitioners (APs), Moffitt Cancer Center reports higher AP retention and recruitment rates, as well as...
On location

AP-Led Team Reduces Procedural Time for Ultrasound-Guided Paracenteses and Thoracenteses

Implementing an advanced practitioner (AP)–led team to perform ultrasound-guided paracentesis and thoracentesis at the bedside decreased patient wait time and use of interventional radiology...
On location

Assessing Current Practice and Future Needs of APs in Oncology Clinical Research

A poster presented at JADPRO Live Virtual 2021 shared results of a study aimed at finding ways to better support and prioritize the role...
On location

Investigating the Combination of Ivosidenib Plus Venetoclax and Azacitidine in IDH-Mutated Myeloid Malignancies

In a small study of patients with IDH1-mutated myeloid malignancies, treatment with ivosidenib plus venetoclax, with or without azacitidine, had an acceptable safety profile and led to high...
On location

Evaluating Two New Options for Hereditary Hemorrhagic Telangiectasia

At EHA2021 Virtual, researchers shared safety and efficacy findings of two agents for the treatment of the rare disease hereditary hemorrhagic telangiectasia (HHT): pazopanib...
Advertisement

Current Issue

November 2021 Bonus ASH Annual Meeting Preview Edition

This issue offers a behind-the-scenes look at this year's annual meeting, and more.

Block title